New England Compounding Pharmacy Reaches $100M Settlement for Meningitis Outbreak

The compounding facility linked to the 2012 meningitis outbreak that killed 64 people has agreed to a settlement of $100 million, according to a Bloomberg report.

New England Compounding Pharmacy in Framingham, Mass., distributed steroid injections tainted with fungus that caused an outbreak spanning 20 states.

The settlement will be directed into a compensation fund that will be distributed to the pharmacy's creditors and victims of the tainted steroid injections, according to the report.

NECC has so far received 322 lawsuits and 3,300 claims of injury in relation to the compounding outbreak, according to the report.

In December 2012, NECC filed for bankruptcy protection due to the number of lawsuits received.

More Articles on Settlements:

Baptist Health Settles False Claims Allegations For $2.5M
Rhode Island HIE Settles With ACLU Over Patient Privacy
5 Things to Know About the Sanford Health Spinal Implant Settlement Agreement

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers